Anteris Technologies (AU:AVR) has released an update.
Anteris Technologies Ltd has announced the issuance of 1,500 new fully paid Ordinary Shares, raising $15,000 through the conversion of unlisted options. The company, known for its innovative structural heart devices, including the DurAVR® transcatheter heart valve, is progressing in its mission to address unmet clinical needs in the structural heart market. The shares were issued under section 708A(5)(e) of the Corporations Act without the need for disclosure to investors.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
